VTAK Catheter Precision, Inc.

NEUTRAL Impact: 4/10 8-K
Horizon weeks Filed Jun 8, 2026 Processed 12d 21h ago SEC 0001437749-26-019779
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Latest settled — T+5d ⚠ clustered
VTAK ▲ +2.94% at T+5d
NEUTRAL call ✓ call won +2.94% · α vs SPY +0.83% · entry $1.02 → $1.05
Next anchor: T+20d in 16d
Last close $0.8400 (close Jun 18) · -17.65% from $1.02 entry
Entry anchored
Jun 5, 03:22 PM ET
via Databento tick
T+1d
-2.25%
call -2.25% · α -1.95%
$0.9971
settled 12d ago
T+5d
+2.94%
call +2.94% · α +0.83%
$1.05
settled 6d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Catheter Precision (VTAK) entered into a Securities Purchase Agreement to purchase 2,941,176 shares of Volato Group (SOAR) common stock at $0.34/share for $1,000,000 in a private placement. As consideration for VTAK's participation, Volato agreed to deliver 451,901 freely tradeable shares of flyExclusive, Inc. common stock to VTAK, valued at approximately $1,100,000 as of June 5, 2026. The transaction is structured as a strategic investment by VTAK in SOAR, with VTAK receiving additional compensation in the form of third-party equity securities.

Key Financial Metrics

Deal Value
$1.0M

Actionable Insight

Monitor the closing conditions and subsequent registration statement filing by Volato. The freely tradeable flyExclusive shares received by VTAK provide a liquid asset that can be sold immediately, while the SOAR shares are restricted until registration. The transaction does not change VTAK's operational outlook but represents a $1,000,000 cash deployment into a strategic investment.

Key Facts

  • VTAK agreed to purchase 2,941,176 shares of SOAR common stock at $0.34/share for an aggregate purchase price of $1,000,000.
  • As consideration for VTAK's participation, Volato agreed to deliver 451,901 freely tradeable shares of flyExclusive, Inc. common stock to VTAK, valued at approximately $1,100,000 as of June 5, 2026.
  • The closing is subject to customary conditions including accuracy of representations, performance of covenants, and absence of a Material Adverse Effect with respect to Volato.
  • VTAK received registration rights requiring Volato to file a resale registration statement on Form S-3 within 10 calendar days and use best efforts to have it declared effective.
  • The total aggregate offering under the Purchase Agreement is approximately $2,210,000 across all purchasers, with VTAK's subscription amount being $1,000,000.

Financial Impact

VTAK deployed $1,000,000 cash to acquire SOAR shares and received approximately $1,100,000 in freely tradeable flyExclusive shares as a participation incentive. Net cash outflow of $1,000,000 with a non-cash compensation asset of ~$1,100,000.

cashinvestmentsequity securities holdings

Risk Factors

  • The closing is subject to conditions including no Material Adverse Effect at Volato — if Volato's business deteriorates, the deal may not close.
  • The $1,000,000 cash outlay reduces VTAK's cash reserves for its own operations.
  • The value of the SOAR shares and flyExclusive shares received is subject to market volatility — there is no guarantee VTAK will realize the current market values through future sales.
  • Registration rights are subject to carve-outs for Excluded Registration Events which could delay resale of SOAR shares.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-019779
Exhibit: ex_973563.htm0001437749-26-019779
Document: vtak20260607_8k.htm0001437749-26-019779
Document: 0001437749-26-019779-index-headers.html0001437749-26-019779
Document: 0001437749-26-019779-index.html0001437749-26-019779
Document: 0001437749-26-019779.txt0001437749-26-019779
11 reports for VTAK
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VTAK — sortable, filterable
Type Now
Jun 8, 2026
12d ago
Press Release
NEUTRAL ★ 3/10
$1.02 $1.05▲ +2.94%▲ +0.83%$0.8400 (−17.65%)
Jun 8, 2026
12d ago
8-K
NEUTRAL ★ 4/10
$1.02 $1.05▲ +2.94%▲ +0.83%$0.8400 (−17.65%)
May 4, 2026
6w ago
Press Release
NEUTRAL ★ 2/10
$0.9400 $0.8100▼ −13.83%▼ −16.77%$0.8400 (−10.64%)
Apr 21, 2026
8w ago
Press Release
BULLISH ★ 6/10
$0.9500 $0.9300▼ −2.11%▼ −3.19%$0.8400 (−11.58%)
Apr 20, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$0.9800 $0.9000▼ −8.16%▼ −9.08%$0.8400 (−14.29%)
Apr 8, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$0.8600 $1.03▲ +19.77%▲ +16.25%$0.8400 (−2.33%)
Apr 6, 2026
10w ago
Press Release
NEUTRAL ★ 4/10
$0.9500 $1.22▲ +28.42%▲ +24.29%$0.8400 (−11.58%)
Mar 31, 2026
11w ago
8-K
MIXED ★ 6/10
$0.9400 $1.21▲ +28.72%▲ +24.96%$0.8400 (−10.64%)
Mar 31, 2026
11w ago
Press Release
MIXED ★ 6/10
$1.01 $0.8600▼ −14.85%▼ −18.80%$0.8400 (−16.83%)
Mar 23, 2026
12w ago
DEFA14A
BEARISH ★ 7/10
$1.20 $1.01▲ +15.83%▲ +15.41%$0.8400 (+30.00%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (29h 31m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access